Osterweis Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-114,190
Closed -$2.58M 113
2019
Q3
$2.58M Buy
114,190
+14,805
+15% +$410K 0.19% 81
2019
Q2
$3.58M Sell
99,385
-20,905
-17% -$669K 0.25% 66
2019
Q1
$3.79M Sell
120,290
-88,260
-42% -$2.57M 0.24% 75
2018
Q4
$5.24M Buy
+208,550
New +$5.36M 0.4% 62

Other funds holding CDNA

Osterweis Capital Management's CDNA Position: Q4 2019 in Review

Osterweis Capital Management sold out of CareDx (CDNA) in Q4 2019, closing a stake of 114,190 shares — an estimated $2.58M sold.

Osterweis Capital Management first reported a position in CDNA in Q4 2018 and held it in 4 quarters. The position peaked at $5.24M in Q4 2018. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

  • Osterweis Capital Management reported no remaining CareDx position as of Q4 2019 after selling out during the quarter.
  • Osterweis Capital Management sold 114,190 CareDx shares in Q4 2019, an estimated $2.58M.
  • Osterweis Capital Management first reported a position in CareDx in Q4 2018 and held it in 4 quarters.
  • Osterweis Capital Management's CareDx position peaked at $5.24M in Q4 2018.
  • 159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Osterweis Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.